The study evaluate the efficacy of intraoperative radiotherapy those who underwent neoadjuvant chemotherapy for pancreatic cancer.
- Conditions
- Neoplasms
- Registration Number
- KCT0005113
- Lead Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
? Histologic diagnosis or clinically suspected of adenocarcinoma of the pancreas based on imaging tests or tumor markers
? Older than 20 years
? The performance status of patients based ECOG score less than 3
? Patients with pancreatic cancer who were either surgically resectable or borderline resectable or can be resected after neoadjuvant chemotherapy because of advanced pancreatic cancer
? Patients who voluntarily decided to participate in this clinical study and signed the written informed consent
? Previous history of irradiation in abdomen
? The treatment site could not be included in the appropriate radiation field, as judged by the radiation oncologist or the surgeon
? In case of distant metastasis
? A systemic condition that, under the judgment of the attending physician, would be difficult for surgery or radiation
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal recurrence rate
- Secondary Outcome Measures
Name Time Method Acute, chronic toxicity;Disease free survival;Overall survival